Biochem.J.(2002)365,783–789(PrintedinGreatBritain)783The4.1/ezrin/radixin/moesindomainoftheDAL-1/Protein4.1Btumoursuppressorinteractswith14-3-3proteinsTingxiYU*1,VictoriaA.ROBB(cid:139)1,VinitaSINGH*,DavidH.GUTMANN(cid:139)andIreneF.NEWSHAM*2*DavidandDoreenHermelinLaboratoryofMolecularOncogenetics,DepartmentofNeurosurgeryandHermelinBrainTumorCenter,HenryFordHospital,E&RBldg.Rm.3096,2799W.GrandBlvd.Detroit,MI48202,U.S.A.,and(cid:139)DepartmentofNeurology,WashingtonUniversitySchoolofMedicine,St.Louis,MO,U.S.A.TheProtein4.1familycontainsatleasttwomembersthatfunctionastumoursuppressors,theneuroﬁbromatosis2geneproductmerlinandtherecentlyidentiﬁeddiﬀerentiallyexpressedinadenocarcinomaofthelung(DAL-1)}Protein4.1Bmolecule.DAL-1}Protein4.1Blossisobservedinavarietyoftumours,includingbreastandlungcancersaswellasmeningiomas.WehavepreviouslydemonstratedthatDAL-1}Protein4.1Binteractswithsomebutnotallmerlin-bindingproteins,raisingthepossibilitythatDAL-1}Protein4.1Bassociateswithadditionaluniqueproteinsspeciﬁctoitsfunctionasanegativegrowthregulator.Usingyeasttwo-hybridinteractioncloning,weidenti-ﬁedthree14-3-3isoforms,b,candg,tobeDAL-1}Protein4.1B-INTRODUCTIONDiﬀerentiallyexpressedinadenocarcinomaofthelung(DAL-1)}Protein4.1BisatumoursuppressorgenebelongingtotheProtein4.1superfamilyofproteins,originallyisolatedusingdiﬀerentialdisplayPCRonprimarylungtumours[1].DAL-1}Protein4.1BrepresentsthesecondmemberoftheProtein4.1familythatfunctionsasatumoursuppressor.Merlinorschwannomin,theﬁrstidentiﬁedProtein4.1tumoursuppressor,isaproductoftheneuroﬁbromatosis2gene[2,3].MembersoftheProtein4.1familycontainseveralregionsofsequencesimilarityincludinga4.1}ezrin}radixin}moesin(FERM)domainconsistingofapprox.300aminoacids,andspectrin}actinbindingsequences[4].TheFERMdomainofthefoundingfamilymem-berProtein4.1Rhasbeenfoundtoassociatewithseveralmembraneproteins,includingerythrocyteband3,calmodulin,glycophorinC,p55andthechloride-ionchannelpICln[5,6].Similarly,merlinassociateswithseveraltransmembraneproteinsviaresiduesintheN-terminalFERMdomain[7,8].Theinter-actionofmerlinwithoneofthesemembraneproteins,CD44,hasbeenshowntobecriticalformerlingrowthsuppression[7,9].Similartomerlin,DAL-1}Protein4.1Blocalizestothecellmembrane[1]andcanfunctionasanegativegrowthregulator.WhenDAL-1}Protein4.1BisreintroducedintoDAL-1-deﬁcientlungcancer[1],breastcancer[10]andmeningioma[11]celllines,cellgrowthissigniﬁcantlyattenuated.Lossofheterozygosityatchromosome18p11.3,thechromosomallocationofDAL-1}Pro-tein4.1B,isfrequentinlung,breastandbraintumours[12].Detailedanalysisofbreastcancertissuesamplesrepresentingmultiplediseasestagesrevealedthat18p11.3allelicdeletionsAbbreviationsused:DAL-1,diﬀerentiallyexpressedinadenocarcinomaofthelung;FERM,4.1/ezrin/radixin/moesin;GST,glutathioneS-transferase;NP40,NonidetP40;TnT,transcriptionandtranslation.1Thesetwoauthorscontributedequallytothepresentstudy.2Towhomcorrespondenceshouldbeaddressed(e-mailirene!bogler.net).bindingproteins.TheseinteractionswereveriﬁedbyusingglutathioneS-transferaseaﬃnitychromatographyin(cid:138)itroandco-immunoprecipitationin(cid:138)i(cid:138)o.Theinteractionof14-3-3withDAL-1}Protein4.1Bwasspeciﬁc,as14-3-3didnotbindtotherelatedProtein4.1familymembersmerlin,ezrinorradixin.TheDAL-1}Protein4.1Bdomainthatmediates14-3-3bindingwasmappedtoresiduesPro#%%andLeu#)!withinthe4.1}ezrin}radixin}moesindomain.TheidentiﬁcationofthisnovelDAL-1}Protein4.1B-interactingproteinrepresentstheﬁrststeptowardselucidatingitspotentiallyuniquemechanismofaction.Keywords:membrane,neuroﬁbromatosis2.occurinatleast55%ofductalcarcinomainsitutumours,suggestingthatlossofDAL-1}Protein4.1Bexpressionoccursearlyintheprogressionofthisdisease[13].Similarly,thelossofDAL-1}Protein4.1Bexpressionisdetectedearlyinmeningiomapathogenesis[14,15].AlthoughmerlinandDAL-1}Protein4.1Bsharestructuralsimilarities,thereareanumberofobservationsthatsuggestthatthesetwoProtein4.1tumoursuppressorshaveuniquemechanismsofaction.First,incelltypeswherebothDAL-1andmerlinareexpressed,sometumoursexhibitonlyNF2loss,whereasothersexhibitonlyDAL-1}Protein4.1Binactivation[14].Secondly,overexpressionofmerlinandDAL-1}Protein4.1Bresultsinthesuppressionofmeningiomacelllinegrowth,butonlymerlinoverexpressioncansuppressschwannomacellgrowthin(cid:138)itro[11].Thirdly,DAL-1}Protein4.1Binteractsonlywithasubsetofmerlin-bindingproteins[11].Andﬁnally,thecombinedlossofbothDAL-1}Protein4.1Bandmerlinismorefrequentlyassociatedwithhigh-grademeningiomas[15].InaneﬀorttoidentifyuniquebindingpartnersforDAL-1}Protein4.1Bthatmayunderlieitsmechanismofactionasanegativegrowthregulator,weperformedyeasttwo-hybridanalysisusingthe336residueDAL-1}Protein4.1BFERMdomain.Over1.5millionco-transfectantsfromafoetalbraincDNAlibrarywerescreenedtoidentifyseveralstronglyas-sociatingproteins,threeofwhichrepresentedthe14-3-3proteinisoformsb,candg.Thesehighlyconservedandubiquitouslyexpressedproteinsareinvolvedintheregulationofenzymeactivity,actaslocalizationanchorsforotherproteins,andfunctionasadaptormoleculestostimulateprotein–proteininter-actions[16].Thebindingofamembrane-associatedproteinsuchasDAL-1}Protein4.1Brepresentsanovelpartnerfor14-3-3.#2002BiochemicalSociety784T.YuandothersInthepresentstudy,wedemonstratethedirectassociationof14-3-3withthetumoursuppressorproteinDAL-1}Protein4.1Bbyco-immunoprecipitationin(cid:138)i(cid:138)oandaﬃnitychromatographyassaysin(cid:138)itro.Wefurthershowthatthe14-3-3interactionwasspeciﬁctoDAL-1}Protein4.1BandnototherProtein4.1familymembers.Lastly,welocalizedtheDAL-1}Protein4.1B–14-3-3interactiondomaintotheaminoacidresiduesPro#%%andLeu#)!withintheFERMdomain.MATERIALSANDMETHODSYeasttwo-hybridanalysistoidentifyproteinsthatinteractwiththeFERMdomainofDAL-1/Protein4.1BYeasttwo-hybridanalysis,utilizedtoidentifytheproteinsinteractingwiththeFERMdomainofDAL-1}Protein4.1B,wasperformedusingtheProQuestTMTwo-Hybridsystem(Invitrogen,Carlsbad,CA,U.S.A.).TheFERMdomainofDAL-1}Protein4.1B,representingtheﬁrst336aminoacidsoftheDAL-1}Protein4.1BcDNAclone2A3(1),wasampliﬁedusingprimers5«-ACGTGTCGACCATGCAGTGCAAAGTG-ATAC-3«and5«-ACGTGCGGCCGCCTCTCCATCCAAGC-TGCG-3«containingSalIandNotIrestrictionenzymesitelinkersrespectively.Theresulting1015bpfragmentwasclonedintothepDBleu‘bait’vector,creatingafusionproteinwithaGAL-4transcriptionfactorDNA-bindingdomain.AfoetalbraincDNAlibrary(Invitrogen)encodingexpressedcDNAsfusedwiththeGAL-4transcriptionfactoractivationdomainwasusedforscreening.Initially,thelibrarywasexpandedinTerriﬁcBrothmedium(1litre;12gofbacto-tryptone,24gofbacto-yeastextract,4mlofglycerol)for16hat30(cid:176)C,andplasmidDNAwasisolatedusingaBio-Radmidiprepkit.MaV200competentcells(Invitrogen)wereco-transformedwith10lgofbaitplasmid(pDBLeu-FERM)and10lgoflibraryplasmidDNA(pPC86-cDNA).Morethan1.5millioncDNAcloneswerescreened,and14positivelyinteractingcolonieswereidentiﬁedonthebasisofgrowthonleucine-,tryptophan-,uracil-andhistidine-lackingplatesaswellastheabilitytoprocessthelacZsubstrate.Toconﬁrmtheprimaryyeasttwo-hybridinteraction,pPC86-cDNAconstructswereisolatedfromthepositiveyeastcoloniesusingtheYeastDNAIsolationSystem(Stratagene,LaJolla,CA,U.S.A.),andinsertsweresequencedandanalysedwitheitherThermosequenaseCy5orCy5.5terminatorsequencingkits(APBiotech)ontheLong-ReadTMSystemsequencer(VisibleGenetics).HomologysearcheswereperformedusingtheBLASTalgorithmfromtheNationalCenterforBiotechnologyInfor-mationwebsite(www.nbti.nlm.nih.gov)[17].CellcultureandWestern-blotanalysisThelungtumourcelllineNCI-H460andbreastcarcinomacelllineT47DwereobtainedfromA.T.C.C.(Manassas,VA,U.S.A.)andmaintainedinRPMI1640}10%foetalcalfserumeitherwithinsulin(T47D)orwithoutinsulin(NCI-H460).TheMCF-7Clone27celllineisaDAL-1}Protein4.1B-induciblecelllinegeneratedfromtheparentalMCF-7celllineusingtheEcdysonemuristerone-inducibleexpressionkit(Invitrogen)[10].ThiscelllineaswellasparentalMCF-7weregrowninMEMwith10%foetalcalfserum,sodiumpyruvate,non-essentialaminoacidsandinsulin.DAL-1}Protein4.1Bexpressionisinducedbytheadditionof1lMofmuristeronetotheculturemediumfor48h.ForWestern-blotanalysisontotalcellularprotein,lysateswerepreparedinRIPAbuﬀer[50mMTris}150mMNaCl}0.1%SDS}0.5%sodiumdeoxycholate}1%NonidetP40(NP40)]withproteaseinhibitors(BoehringerMannheim,Indianapolis,IN,U.S.A.).ElectrophoresiswasperformedonSDS}PAGE(10%or12%gel)ReadyGels(Bio-Rad)andtransferredontoPVDFPlusmembrane(MSIInc.)usingtheBio-RadMiniProteanIItransfersystemasdescribedpreviously[1].Forspeciﬁcextractionofcytoplasmicandmembraneproteinfractions,cellswereresuspendedin20mMHepes,40mMb-glycerophosphate,2mMMgCl#,1mMorthovanadateandproteaseinhibitors(BoehringerMannheim),andlysedfor10minat4(cid:176)C.Sampleswerecentri-fugedfor30minat17000rev.}min.Thesupernatant,repre-sentingthecytosolicfraction,wasseparatedfromthepellet,and2%NP40wasadded.Freshlysisbuﬀerincluding2%NP40wasaddedtothepelletsrepresentingthecellularmembranefraction.Followingincubationfor10minat4(cid:176)C,sampleswerecentri-fugedandthemembranefractionsupernatantcollected.InvitrobindingassayspcDNA414-3-3b,14-3-3cand14-3-3gcDNAexpressioncon-structsweregeneratedbyPCRampliﬁcationofthecodingregionsofthe14-3-3proteinspresentintheyeasttwo-hybridpPC86-cDNAconstructs.Ampliﬁcationprimers,containingrestrictionenzymelinkersequencesforEcoRIandXbaI(underlined),werethefollowing.14-3-3bforwardprimer5«-GGAATTCCCCACGGGAATGACAATGGAT-3«and14-3-3breverseprimer5«-GCTCTAGAGCATTAGTTCTCTCC-CTCCCCA-3«;14-3-3cforwardprimer5«-GGAATTCCGAG-CCGCGAGCGACATG-3«and14-3-3creverseprimer5«-GCTCTAGAGCGGCTAATTCTTTCTAATC-3«;and14-3-3gforwardprimer5«-GGAATTCCCGAAGATGGTGGACCG-CGAGC-3«and14-3-3greverseprimer5«-GCTCTAGAGCC-TGGGGCCTTAATTGTTGC-3«.GeneratedpcDNA4-14-3-3constructswereveriﬁedbysequencing.GlutathioneS-transferase(GST)–DAL-1}Protein4.1BfusionproteinwasexpressedinBL-21cells(Novagen)followingin-ductionwith0.4mMisopropylb-d-thiogalactosideandisolatedusingtheBugBusterTMGST-BindTMpuriﬁcationkit(Novagen).[$H]Leucine-labelled14-3-3b,14-3-3cand14-3-3gproteinsweregeneratedbyacoupledin(cid:138)itrotranscriptionandtranslation(TnT)kit(Promega,Madison,WI,U.S.A.).Forin(cid:138)itrobindingassays,individuallylabelledproteinswereconfrontedwith2lgofGST–DAL-1fusionproteinusingBugBusterbinding}washbuﬀer(4.3mMNa#HPO%}1.47mMKH#PO%}137mMNaCl}2.7mMKCl,pH7.3).ComplexeswerecollectedonGST-Bindresin(Novagen),washedthreetimeswithTris-buﬀeredsaline}0.3%(v}v)Tween20,andseparatedonSDS}PAGE(10%gel)ReadyGels(Bio-Rad).Gelswereﬁxedinapropan-2-ol}water}aceticacid(25:65:10)solution,andﬂuoro-graphicsignalswereenhancedusingAmplifyTM(Amersham).Vacuum-driedgelswereexposedtoautoradiographicﬁlmfor1–2days.Co-immunoprecipitationProteinlysateswerepreparedasdescribedabovefromthecelllinesNCI-H460,T47DandMCF-7andfromMCF-7Clone27beforeandaftera48hinductionofDAL-1(residues1–503)expressionwith1lMofmuristerone.Immunoprecipitatesweregeneratedfrom1–2mgoflysateusingeitherpolyclonalpananti-14-3-3(H8;SantaCruzBiotechnology,NewYork,NY,U.S.A.),anti-14-3-3b(C-20;SantaCruzBiotechnology),anti-14-3-3c(C-16;SantaCruzBiotechnology)orthepolyclonalanti-DAL-1}Protein4.1Bantibody3A-1.Antibodiesweremixedwithcelllysatesandincubatedat4(cid:176)Covernightwithrotation.Immuno-precipitateswerecollectedonProteinA–agarosebeads(RocheMolecularBiochemicals,Laval,Quebec,Canada),elutedin2‹#2002BiochemicalSociety785DAL-1interactswith14-3-3proteinsLaemmlisamplebuﬀer,andelectrophoresedonSDS}PAGE(10%or12%gel)ReadyGels(Bio-Rad).BoundproteinswerethenidentiﬁedbyWestern-blotanalysisusingeitheranti-14-3-3antibodies(1:1000)ortheanti-DAL-1}Protein4.1Bantibody(1:2000)detectedwiththemouseIgGorrabbitIgGImmunStarChemiluminescencekits(Bio-Rad).GSTafﬁnitychromatographyGSTfusionproteinsweregeneratedasdescribedpreviously[11].Brieﬂy,GST–14-3-3gfromtheoriginalpPC86yeasttwo-hybridvector(Invitrogen)wasclonedintothepGEX.4T-2vector(Pharmacia),veriﬁedbysequencingandtransformedintoDE3(BL-21)-competentcellsforfusionproteinproduction.Bacterialcultureswereinducedovernightwith0.5mMisopropylb-d-thiogalactosideatroomtemperature,lysedinNP40lysisbuﬀerandtheGSTfusionproteinsisolatedonglutathione–agarosebeads(Sigma)fortheinteractionexperiments.EachfusionproteinwasnewlyisolatedforeachexperimentandveriﬁedbySDS}PAGEwithCoomassieBluevisualization.DAL-1}Protein4.1B,merlin,ezrin(N-ezrin,C-ezrin)andradixin(mer-radandrad-mer)weregeneratedbyreversetrans-criptasePCRasdescribedpreviously[18].Rad-merisahybridproteincomprisedoftheN-terminalradixinsequences(1–323)joinedinframewithC-terminalmerlinsequences(341–583),whereasmer-radiscomposedofN-terminalmerlin(1–341)andC-terminalradixinsequences(324–583).DAL-1}Protein4.1Bconstructs,schematicallyshowninFigure5(A),werecreatedusingfull-lengthDAL-1}Protein4.1BasatemplateandtheTAcloningkit(Invitrogen)accordingtothemanufacturer’sinstructions.ConstructMet"wasgeneratedbyPCRusingprimersthatamplifytheFERMdomainalone(FermF:5«-GCA-CTA-GTC-AAG-GAC-TCA-GAA-GGG-GTA-G-3«andFermR:5«-TCA-TGC-AGC-AGA-CAT-AGA-ATC-CTT-C-3«).Con-structsLys"*&,Pro#%%andLeu#)!weregeneratedbyPCRusingthereverseprimerU2R(5«-TCA-CTC-AGT-GGC-GGT-GGT-CTC-3«)anduniqueforwardprimers(K195F:5«-CAC-TAG-TCC-CGG-GAG-AGT-TTG-AAC-AAT-TTG-3«,P244F:5«-GCA-CTA-GTC-CTG-TTA-CCA-GAA-GCA-CCT-CCC-3«andL280F:5«-TCA-CTT-GGG-AGG-TGC-TTC-TGG-TAA-CAG-3«).ConstructsMet"–#%%andMet"–#)!,encompassingtheﬁrst244and280aminoacidsrespectivelyoftheFERMdomainofDAL-1,weregeneratedbyPCRusingtheforwardprimerFermFanduniquereverseprimers(P244R:5«-TCA-CGG-CCG-GAT-CTT-AAT-GTA-AAA-GTT-3«andL280R:5«-TCA-CAG-TAG-TCT-GAA-AAA-TGT-ATG-ATG-3«).Thecon-structswereveriﬁedbysequencing,andthensubclonedintothepcDNA3vector(Invitrogen).Proteinsweresynthesizedbythein(cid:138)itrocoupledTnTmethod(Promega;catalogno.L4610)inthepresenceof[$&S]methionineaccordingtothemanufacturer’sprotocolandconﬁrmedbySDS}PAGEandautoradiography.Interactionexperimentswereperformedbyincubating5lloftheTnTreactioncontainingtheradiolabelledproteinswithequi-molaramountsofGSTfusionproteinsimmobilizedongluta-thionebeadsinatotalvolumeof1mlofTENbuﬀer[10mMTris(pH7.5)}150mMNaCl}5mMEDTA}1%(v}v)TritonX-100]for4hat4(cid:176)C.TheboundagarosebeadswerethenwashedfourtimesinTENbuﬀer.ForassaysusingproteinfragmentsMet"−#%%andMet"–#)!,radiolabelledproteinsin5llofTnTreactionbuﬀerwereincubatedwithequimolaramountsofGSTfusionproteinsimmobilizedonglutathionebeadsinatotalvolumeof1mlofNETbuﬀer[25mMTris(pH7.5)}100mMNaCl}3mMEDTA]containing1%BSAfor4hat4(cid:176)C.BeadswerewashedtwicewithNETbuﬀerplus0.1%(v}v)TritonX-100andtwicewithNETbuﬀerplus0.05%(v}v)TritonX-100.Analiquotoftheunboundfractionwassavedforalltheassays.TheunboundandboundfractionswereelutedinLaemmlibuﬀer,boiledfor5min,separatedbySDS}PAGEandanalysedbyautoradiography.IdenticalresultswereobtainedwitheitherNETorTENbuﬀers.Inallexperiments,signiﬁcantbindingtoimmobilizedGSTalonewasnotobserved.Eachinteractionexperimenthasbeenrepeatedatleastthreetimes.RESULTSDAL-1/Protein4.1Binteractswithmembersofthe14-3-3familyYeasttwo-hybridinteractioncloningwasperformedtoisolatepotentialbindingpartnersofthetumoursuppressorproteinDAL-1}Protein4.1B.TheFERMdomainofDAL-1}Protein4.1B(Met"-Gly$$’)wasfusedinframewiththeDNA-bindingdomainofGAL4inthepDBleubaitvectorandusedtoscreenahumanfoetalbraincDNAlibrary.ThehighexpressionofDAL-1}Protein4.1Binthebrain[1]suggeststhatphysio-logicallyrelevantbindingpartnerswouldberepresentedinthislibrary.Analysisofmorethan1.5millionco-transfectantsledtotheisolationofatotalof14positiveclonesaftertworoundsofscreening.Threeofthesecolonies(g4,g14andg41inFigure1)containedcDNAsencodingthe14-3-3b,14-3-3cand14-3-3gisoforms.ThecDNAinsertsizesrangedfrom1.6to4.0kbandsequenceanalysisconﬁrmedrepresentationoftheentirecodingregionofthese14-3-3proteinsinthecDNAisolates.ToconﬁrmtheinteractionbetweenDAL-1}Protein4.1Band14-3-3inmammaliancellextracts,co-immunoprecipitationexperimentswereperformedusingproteinlysatesfromtheendogenouslyexpressingnon-smallcelllungcancercellline(NCI-H460),DAL-1}Protein4.1B-nullbreastcancercellline(MCF-7)andFigure114-3-3interactswiththeFERMdomainofDAL-1/Protein4.1BAfoetalbraincDNAlibrarywasscreenedwiththeFERMdomainofDAL-1/Protein4.1Basbait.Theresultingco-transfectantsexhibitinginteractionwereselectedinpartfortheirabilitytoinducetranscriptionofthelacZgeneresultinginabluecolourwhenassayedwith5-bromo-4-chloroindol-3-ylb-D-galactopyranoside.Co-transfectantsg4,g14andg41werepositiveforlacZexpression,whereasg36wasnegative.Controlsrepresentingknownproteininteractionsofvaryingstrengthwereplatedforcomparison.(A)NocDNAinsertcontrol;(B)RB/E2F,weakinteraction;(C)DrosophilaDP/E2F,moderateinteraction;(D)Fos/Jun,stronginteraction;(E)GAL4-bindingdomain/GAL4-activationdomain,verystronginteraction.#2002BiochemicalSociety786T.YuandothersFigure2DAL-1/Protein4.1Binteractsdirectlywith14-3-3b,14-3-3gand14-3-3cinmammaliancellextracts(A)DAL-1/Protein4.1Band14-3-3proteinsfromNCI-H460,MCF-7andtheDAL-1-induciblecelllineClone27weretestedfortheirabilitytoco-immunoprecipitate.Productsimmuno-precipitatedwiththepolyclonalanti-DAL-1/Protein4.1Bantibody3A-1wereanalysedbyWestern-blotanalysiswitheithertheDAL-1/Protein4.1BantibodyorthepolyclonalH8anti-14-3-3antibody.AnalysisshowedthatendogenousDAL-1/Protein4.1Bprotein(fromNCI-H460)andDAL-1proteininducedaftera48hexposureto1lMofmuristerone(Cl.27›)wasabletoco-immunoprecipitatewith14-3-3proteins.CelllinesnegativeforDAL-1/Protein4.1Bexpression(MCF-7andCl.27ﬁ)didnotshowinteractionwith14-3-3.Theendogenouslevelof14-3-3proteinsinthesecelllinesisshowninthelowerpanel.(B)EndogenouslyexpressedDAL-1/Protein4.1Bwasexaminedforitsabilitytointeractspeciﬁcallywiththeendogenousbandcisoformsof14-3-3inNCI-H460andT47D.Western-blotanalysiswith14-3-3bor14-3-3c-speciﬁcantibodiesfollowingimmunoprecipitationwithDAL-1/Protein4.1Bantibody3A-1revealedastrongbandforeachisoform,indicatingthatDAL-1/Protein4.1Band14-3-3proteinscaninteract.(C)GST–DAL-1fusionprotein(2lg)wasgeneratedandinteractedinvitrowithradiolabelled14-3-3b,14-3-3cand14-3-3g.AliquotsofeachradiolabelledproteinfromtheinvitroTnTreactionswererunasareference(TnTrxn).EquivalentamountsofproteincollectedonGSTbeadsandremaininginthesupernatantwereanalysedbyelectrophoresisandautoradiography.Allthree14-3-3isoformstesteddirectlyinteractedwiththeGST–DAL-1fusionprotein.IP,immunoprecipitation;Ab,antibody.aDAL-1inducibleMCF-7-derivedcellline(Clone27),inwhichexpressionofDAL-1(residues1–503)isinducedaftertreatmentwith1lMmuristeroneinculture[10].AsshowninFigure2(A),allcelllinesexpressedabundantlevelsof14-3-3proteins,whereasonlyNCI-H460andtheDAL-1-inducibleMCF-7Clone27(Cl.27›)showedadetectableDAL-1}Protein4.1Bprotein.Immunoprecipitationusingthepolyclonalanti-DAL-1}Protein4.1Bantibody3A-1followedbyWestern-blotanalysisof14-3-3proteinsusingthemonoclonalpan-14-3-3(H8)antibodydemonstratedaninteractioninmammaliancellextractsonlywhentheProtein4.1B}DAL-1proteinwasconcurrentlyex-pressed(Figure2A).Speciﬁcisoformbindingwasexaminedbyusingavailablemonoclonalantibodiesagainst14-3-3c(C-16)and14-3-3b(C-20).AsshowninFigure2(B),14-3-3band14-3-3cwereequallyexpressedinNCI-H460andtheendogenousDAL-1}Protein4.1B-expressingbreastcancercelllineT47D.Inbothcases,14-3-3cand14-3-3bco-immunoprecipitatedwithDAL-1}Protein4.1B,indicatingthistumoursuppressorproteinhasageneralizedcapabilitytointeractwithvarious14-3-3isoforms.boundsupernatantMerlinEzrinDAL-1GSTGSTGST·14-3-3GST·14-3-3RadixinFigure314-3-3bindsspeciﬁcallytoDAL-1/Protein4.1BBindingof14-3-3toDAL-1/Protein4.1B,merlin,ezrinandradixinwasinvestigatedbyGSTaﬃnityinteractionsusingGSTaloneorGST–14-3-3gasdescribedintheMaterialsandmethodssection.Theboundandsupernatantfractionsareshownforeachrepresentativeinteraction.DAL-1/Protein4.1Bexhibitedsigniﬁcantbindingto14-3-3.Bindingtomerlin,ezrinorradixin(rad-mer,resultsshown;mer-rad,resultsnotshown)wasnotobserved.Figure414-3-3complexeswithDAL-1/Protein4.1BattheplasmamembraneProteinlysateswereisolatedfromtheDAL-1/Protein4.1B-induciblecelllineClone27,beforeandafter48hexposuretotheexpression-inducingagentmuristerone.Totalcelllysate(TCL)orproteinisolatedfromfractionsrepresentingplasmamembrane(Mem)orcytoplasmic(Cyt)componentswereimmunoprecipitatedusingthe14-3-3cantibody,followedbyWestern-blotanalysiswiththepolyclonalDAL-1/Protein4.1Bantibody3A-1.ResultsshowthatDAL-1proteinexpressionissigniﬁcantlyinduceduponexposuretomuristerone.ThemajorityofDAL-1proteinproducedcanbeimmunoprecipitatedfromthemembranecomponentbythe14-3-3antibody,indicatingthat14-3-3proteinsarefoundcomplexedwithDAL-1proteinsattheplasmamembrane.IgG,immunoglobulinheavychain;kD,kilodalton;ﬁ,withoutinductionofDAL-1proteinexpression;›,withinductionofDAL-1proteinexpression.In(cid:138)itrobindingassayswerealsoperformedtorevealwhethertheseproteinsinteractedinadirectmannerorrequiredthepresenceofothercellularproteins.BacteriallygeneratedGST–DAL-1fusionprotein(residues1–503)wasincubatedwitheitherradiolabelled14-3-3b,14-3-3cor14-3-3gproducedbyin(cid:138)itrocoupledTnT(Figure2C).ComplexedproteinswereretrievedonGSTaﬃnitybeads,afterwhichthepresenceofradiolabelled14-3-3proteinwasanalysedbySDS}PAGEseparationandauto-radiography.AsshowninFigure2(C),signiﬁcantbindingof[$H]-14-3-3b,[$H]-14-3-3cand[$H]-14-3-3gtotheGST–DAL-1fusionproteinwasobserved,suggestingthatDAL-1}Protein4.1Bdirectlyinteractswith14-3-3proteins.NosigniﬁcantbindingtoGSTproteinalonewasfound(resultsnotshown).14-3-3bindingisspeciﬁctoDAL-1/Protein4.1BTodeterminewhetherthe14-3-3interactionwasuniquetoDAL-1}Protein4.1Borwasobservedwithothermembersofthe#2002BiochemicalSociety787DAL-1interactswith14-3-3proteinsFigure5Deﬁnitionofthe14-3-3-bindingdomain(A)Schematicofthedomainspresentinfull-lengthDAL-1/Protein4.1Bandconstructsdesignedtodeterminetheminimum14-3-3-bindingdomain.LettersandnumberscorrespondtotheﬁrstaminoacidresidueofDAL-1/Protein4.1Bandtheconstructs(e.g.Met1correspondstotheinitiatingmethionineofDAL-1/Protein4.1B).Met1–244andMet1–280representN-terminalproteinfragmentsoftheFERMdomainalone.(B)14-3-3bindingtoDAL-1,Met1,Lys195,Pro244,Leu80,Met1–244andMet1–280.GSTaﬃnityinteractionswereperformedusingGSTaloneorGST–14-3-3g.Theboundandsupernatantfractionsareshownforeachrepresentativeinteraction.DAL-1/Protein4.1B,Met1,Lys195,Pro4andMet1–280exhibitedconsiderablebindingto14-3-3.SigniﬁcantbindingtoGSTalone,Leu280orMet1–244wasnotobserved.The37-amino-acidsequenceofDAL-1/Protein4.1B,hypothesizedtocomprisetheputative14-3-3-bindingsequence,isshownatthebottomright.Protein4.1family,in(cid:138)itrointeractionexperimentswerenextperformedusingbacterialGST–14-3-3gandradiolabelledPro-tein4.1familymembers.Consistentwiththeresultsobtainedfromtheyeasttwo-hybridandco-immunoprecipitationassays,14-3-3interactsspeciﬁcallywithDAL-1}Protein4.1B(Figure3),butnottotheProtein4.1familymembersmerlin,ezrinorradixin.Theselectivityofthe14-3-3interactionsuggeststhatsuchspeciﬁcpartnershipsmayberesponsiblefordeﬁningpo-tentialuniquegrowth-regulatoryfunctionsforDAL-1}Protein4.1B.14-3-3iscomplexedwithDAL-1/Protein4.1BattheplasmamembraneAs14-3-3proteinsareabundantlyexpressedcytoplasmicproteinswithanaﬃnityforavarietyofcellularproteins,weaskedwhether14-3-3wasboundtoDAL-1}Protein4.1Battheplasmamembrane.Toaddressthisquestion,celllysatesweregeneratedfromtheMCF-7Clone27induciblecelllinebeforeandafterinductionofDAL-1proteinexpression.Lysateswereimmuno-precipitatedwiththe14-3-3cantibodyandanalysedbyWesternblottingusingtheDAL-1}Protein4.1Bantibody.AsshowninFigure4,DAL-1}Protein4.1BproteinexpressionwasinducedintheMCF-7Clone27celllineafterincubationwith1lMofmuristerone.Isolationofplasmamembraneproteinsfollowedbyimmunoprecipitationrevealedthat14-3-3cwascomplexedwiththeDAL-1proteinattheplasmamembrane.Thisco-localizationsuggeststhatasigniﬁcantproportionof14-3-3proteinisboundtoDAL-1attheplasmamembrane.Reciprocalimmuno-precipitationexperimentswiththeDAL-1}Protein4.1BantibodyfollowedbyWestern-blotanalysiswith14-3-3cor14-3-3bwerealsoattempted;however,buﬀerconditionsusedforcellularfractionationprecludedtheabilityoftheDAL-1}Protein4.1Bantibodytofunctioneﬀectivelyintheimmunoprecipitationreactions.14-3-3interactionrequiresspeciﬁcFERMdomainsequencesTheuseoftheisolatedFERMdomain(Met"-Gly$$’)ofDAL-1}Protein4.1Bintheinitialyeasttwo-hybridscreensuggestedthatthisregioncontainsa14-3-3-bindingsequence.TodeﬁnetheDAL-1}Protein4.1Bsequencethatmediatestheassociationwith14-3-3,wegeneratedaseriesofdeletionconstructsthatremovespeciﬁcregionsoftheFERMdomainofDAL-1}Protein4.1B.#2002BiochemicalSociety788T.YuandothersTheseconstructs,clonedintopcDNA3andusedtogeneratemoleculesforin(cid:138)itroTnT,includetheentireFERMdomain(Met")aswellassequentialN-terminalFERMdomaindeletions,designatedLys"*&,Pro#%%andLeu#)!(Figure5A).Radio-labelledDAL-1}Protein4.1Bproteinfragmentsandthe503resi-dueDAL-1moleculewereincubatedwithGSTorGST–14-3-3gandassayedfortheirabilitytointeractin(cid:138)itro(Figure5B).Intheseexperiments,DAL-1andconstructswithadeletionoftheﬁrst195or244aminoacidsmaintainedtheabilitytocomplexwithGST–14-3-3g.However,deletionoftheaminoacidsbetweenPro#%%andLeu#)!abolished14-3-3gbinding,suggestingthatthis37-amino-acidregion(Pro#%%-Leu#)!)containsresiduescriticalfor14-3-3binding.Todeterminethispossibilityandtoexcludethepossibilitythatcarboxyl-terminalsequencesintheU2regionalsoparticipatein14-3-3binding,wegeneratedtwoadditionalconstructsthatincludeonlyFERMdomainsequences(Met"−#%%andMet"–#)!;Figure5A)andanalysedtheirabilitytointeractwith14-3-3gin(cid:138)itro.OnlytheMet"–#)!FERMfragmentretainedtheabilitytocomplexwith14-3-3(Figure5B).Collectively,theseresultssuggestthattheFERMdomainresiduesPro#%%-Leu#)!aresuﬃcienttomediatethebindingofDAL-1}Protein4.1Bto14-3-3.ThesequenceofthisputativebindingdomainisshowninFigure5(B).Aconventional14-3-3-bindingsite,representedbyconsensussequenceofRSXpSXP[19],isnotfoundwithinthis37-amino-acidstretch.Aminoacidanalysisalsofailedtoidentifyhomologytoanyoftheotherpreviouslyreported14-3-3-bindingmotifs[20],suggestingthatthisinteractioninvolvesanovelinteractionsequence.DISCUSSIONPreviousstudieshavedemonstratedthetumoursuppressorpropertiesoftheDAL-1}Protein4.1Bmolecule[1,10,11].InaneﬀorttoidentifyuniquebindingpartnersforDAL-1}Protein4.1Bthatmaytransduceitsnegativecell-growth-regulatorysignal,weutilizedayeasttwo-hybridinteractionassaywiththeDAL-1}Protein4.1BFERMdomainasbait.Thisscreenidenti-ﬁedthe14-3-3adaptorproteinasaDAL-1}Protein4.1B-interactingmolecule.Wedemonstratedthat14-3-3doesnotassociatewithotherProtein4.1familymembersincludingmerlin,ezrinandradixin.TheDAL-1}Protein4.1B–14-3-3interactionwasconﬁrmedbothin(cid:138)itroandin(cid:138)i(cid:138)o,andappearedtobeadirectassociationthatdoesnotrequireadditionalproteinpartners.Theregionof14-3-3bindingwithintheDAL-1}Protein4.1BFERMdomainlocalizedtoaspeciﬁc37-amino-acidsequencethatdoesnotcontaintraditional14-3-3-bindingmotifs.14-3-3proteinsconsistofsevenprimaryisoforms(b,c,e,f,g,sandh)withadditionalisoformsaanddrepresentingphosphoryl-atedformsofbandfrespectively[21].Theseproteinsexistasdimers,formingtwointernalpocketswithwhichotherproteinscaninteract[22].Inourstudies,wefoundthatall14-3-3moleculesexaminedwereabletobindtoDAL-1}Protein4.1B.TheassociationbetweenDAL-1}Protein4.1Band14-3-3appearstobedirect,basedonin(cid:138)itroaﬃnitychromatographybindingexperiments,althoughotherproteinsmaysubtlyfacilitateorregulatethisinteractionin(cid:138)i(cid:138)o.14-3-3moleculestypicallybindtoproteinsthatcontaintra-ditionalconsensusbindingmotifs,suchasRSXpSXP,althoughotherbindingmotifshavebeenreported.Forexample,proteinphosphatasePTPH1,arelatedProtein4.1familymember,hasbeenshowntobind14-3-3bviatwoC-terminalmotifs,RSLS$&*VEandRVDS)&$EP[23].UsingaseriesofFERMdeletionconstructs,wenarrowedtheDAL-1}Protein4.1B–14-3-3-bindingsitetoa37-amino-aciddomainthatlackspreviouslyreported14-3-3-bindingmotifs.BLASTsearchesfailedtoidentifyotherproteinswiththis37aminoaciddomain,asidefromotherknownFERM-containingmolecules.Inthisregard,theDAL-1}Protein4.1BFERMinteractionsequenceisunique[16,19,20].Phosphorylationhasbeendemonstratedtobeanimportantmodiﬁcationforproteinsinteractingwith14-3-3isoforms.Forexample,theassociationbetween14-3-3andPTPH1isdependentonserinephosphorylation[23].Likewise,theactivationoftheNa+}H+exchanger-1protein,whichinteractswith14-3-3usingthemotifRIGSDP,isalsodependentonthephosphorylationoftheserinewithinthismotif[24].However,phosphorylation-independentpeptidebindingof14-3-3alsooccurs.14-3-3ebindstocalmodulin,aknowninteractorofseveralDAL-1}Protein4.1B-relatedProtein4.1familymolecules,inanon-phosphoryl-ation-dependentmanner[25].ThereforemoleculeslikeDAL-1}Protein4.1Bmightusenon-traditionalandphosphorylation-independentinteractionmechanismstointeractwith14-3-3.Studiesareunderwaytodeterminewhether14-3-3bindingisinﬂuencedbyDAL-1}Protein4.1Bphosphorylationin(cid:138)i(cid:138)o.TheinteractionofDAL-1}Protein4.1Bwith14-3-3isnotaubiquitouscharacteristicofallmembersoftheProtein4.1family.OurstudiesdemonstratedthattheFERMdomainsofmerlin,ezrinandradixinwerenotcapableofassociatingwith14-3-3.Theseresultsstronglysuggestthat14-3-3mayrepresentauniqueinteractorspeciﬁctotheDAL-1}Protein4.1Btumoursuppressor.PreviousstudiesfromourlaboratorieshavedemonstratedthatalthoughmerlinandDAL-1}Protein4.1Barestructurallysimilarmolecules,theydiﬀerintheirabilitytointeractwithspeciﬁcproteins[11].Merlinhasbeenshowntobindtoseveralproteinsthatresideatthecellmembrane,includingCD44andb1-integrin[7,8].TheassociationofmerlinwithCD44isrequiredformerlingrowthsuppression[7,9].Inaddition,merlinassociateswiththehepatocytegrowth-factor-regulatedtyrosinekinasesubstrate[26],Na+}H+exchangerregulatoryfactor[27],syntenin[28]andschwannomin-interactingprotein1[29].Todate,wehaveshownthatDAL-1}Protein4.1Bdoesnotinteractin(cid:138)itrowitheitherthehepatocytegrowth-factor-regu-latedtyrosinekinasesubstrateorschwannomin-interactingpro-tein1andlacksthebindingdomainrequiredforsynteninbinding([11];V.A.RobbandD.H.Gutmann,unpublishedwork).Collectively,theseresultssuggestthatmerlinandDAL-1}Protein4.1Bareuniquemoleculesimportantforgrowthregulation.Although14-3-3isdescribedasacytoplasmicprotein,wehaveshownherethat14-3-3isoformsassociatewithDAL-1}Protein4.1Batthecellmembrane.ItispossiblethatDAL-1}Protein4.1Brecruits14-3-3tothecellmembrane,allowingittointeractwithspeciﬁceﬀectorproteinstotransduceagrowthsuppressorsignal.Asimilarmechanismhasbeenproposedfor14-3-3bindingtoRAF[30–32].Alternatively,14-3-3proteinsmaybeguidingDAL-1}Protein4.1Btotheplasmamembrane,ashasbeensuggestedforother14-3-3-interactingproteins[16,19].Ineithercase,understandingtherelationshipbetweenDAL-1}Protein4.1Band14-3-3islikelytoyieldimportantinsightsintothemechanismsthatregulateDAL-1}Protein4.1Bfunction.Severalotherfunctionshavebeenattributedto14-3-3molecules,includingregulationofsignaltransductionthroughc-Cbl[33]andphosphoinositide3-kinase[34].Oneintriguing14-3-3-bindingpartneristhepro-apoptoticprotein,Bcl-2}Bcl-XL-antagonist,causingcelldeath(BAD)[35].14-3-3bindstophosphorylatedBADandpreventsitfromtranslocatingtothemitochondriatoinitiateprogrammedcelldeathorapoptosis[36,37].Recentwork[10]fromourlaboratorieshasshownthatDAL-1}Protein4.1Boverexpressionresultsinapoptosisinbreastcancercelllines.Atpresent,therelationshipbetweenDAL-1}Protein4.1B,programmedcelldeathand14-3-3bindingis#2002BiochemicalSociety789DAL-1interactswith14-3-3proteinsactivelybeinginvestigated.TheseanalyseswillrequireabetterunderstandingofthespeciﬁcresiduesinDAL-1}Protein4.1Bthatareneededformediating14-3-3binding.Experimentsinourlaboratorydemonstratethatthe37-amino-acidregionnecessaryfor14-3-3bindingoverlapswithregionsthatnotonlymediateothercriticalDAL-1}Protein4.1BassociationsbutalsospecifythecorrectsubcellularlocalizationofDAL-1}Protein4.1Btotheplasmamembrane(D.H.GutmannandI.F.Newsham,unpublishedwork).ExperimentsareunderwaytoidentifyspeciﬁcresidueswithintheFERMdomainwhosealterationselectivelyimpairsDAL-}Protein4.1Bbindingto14-3-3withoutaﬀectingotherbindingproteins.Thesemutantswillbecriticaltodecipheringthefunctionalsigniﬁcanceofthe14-3-3associ-ationtoDAL-1}Protein4.1Bregulationofcellgrowth.WethankDrOliverBo$glerforhelpwiththeyeasttwo-hybridanalysisandW.LiandA.C.Hirbeforexperttechnicalassistance.ThisworkwassupportedbygrantsNS/CA41520andNCI/CA77730toD.H.G.andI.F.N.respectivelyandbythegenerosityoftheHermelinBrainTumorCenterdonors.REFERENCES1Tran,Y.K.,Bo$gler,O.,Gorse,K.M.,Wieland,I.,Green,M.R.andNewsham,I.F.(1999)AnovelmemberoftheNF2/ERM/4.1superfamilywithgrowthsuppressingpropertiesinlungcancer.CancerRes.59,35–452Trofatter,J.A.,MacCollin,M.M.,Rutter,J.L.,Murrell,J.R.,Duyao,M.P.,Parry,D.M.,Eldridge,R.,Kley,N.,Menon,A.G.,Pulaski,K.etal.(1993)Anovelmoesin-,ezrin-,radixin-likegeneisacandidatefortheneuroﬁbromatosis2tumorsuppressor.Cell(Cambridge,Mass.)72,791–8003Rouleau,G.A.,Merel,P.,Lutchman,M.,Sanson,M.,Zucman,J.,Marineau,C.,Hoang-Xuan,K.,Demczuk,S.,Desmaze,C.,Plougastel,B.etal.(1993)Alterationinanewgeneencodingaputativemembrane-organizingproteincausesneuroﬁbromatosistype2.Nature(London)363,515–5214Chishti,A.H.,Kim,A.C.,Marfatia,S.M.,Lutchman,M.,Hanspal,M.,Jindal,H.,Liu,S.-C.,Low,P.S.,Rouleau,G.A.,Mohandas,N.etal.(1998)TheFERMdomain:auniquemoduleinvolvedinthelinkageofcytoplasmicproteinstothemembrane.TrendsBiochem.Sci.23,281–2825Marfatia,S.M.,Lue,R.A.,Branton,D.andChishti,A.H.(1994)Invitrobindingstudiessuggestamembrane-associatedcomplexbetweenerythroidp55,Protein4.1,andglycophorinC.J.Biol.Chem.269,8631–86346Tang,C.-J.andTang,T.K.(1998)The30-kDadomainofProtein4.1mediatesitsbindingtothecarboxylterminusofpICln,aproteininvolvedincellularvolumeregulation.Blood92,1442–14477Morrison,H.,Sherman,L.S.,Legg,J.,Banine,F.,Isacke,C.,Haipek,C.A.,Gutmann,D.H.,Ponta,H.andHerrlich,P.(2001)TheNF2tumorsuppressorgeneproduct,merlin,mediatescontactinhibitionofgrowththroughinteractionswithCD44.GenesDev.15,968–9808Obremski,V.J.,Hall,A.M.andFernandez-Valle,C.(1998)Merlin,theneuroﬁbromatosistype2geneproduct,andb1integrinassociateinisolatedanddiﬀerentiatingSchwanncells.J.Neurobiol.37,487–5019Sherman,L.S.andGutmann,D.H.(2001)Merlin:hangingtumorsuppressionontheRac.TrendsCellBiol.11,442–44510Charboneau,A.L.,Singh,V.,Yu,T.andNewsham,I.F.(2002)ThetumorsuppressorDAL-1suppressesgrowthinMCF-7cells.Int.J.Cancer,inthepress11Gutmann,D.H.,Hirbe,A.C.,Huang,Z.-Y.andHaipek,C.A.(2001)TheProtein4.1tumorsuppressor,DAL-1,impairscellmotility,butregulatesproliferationinacell-type-speciﬁcfashion.Neurobiol.Dis.8,266–27812Tran,Y.,Benbatoul,K.,Gorse,K.,Rempel,S.,Futreal,A.,Green,M.andNewsham,I.(1998)Novelregionsofallelicdeletiononchromosome18pintumorsofthelung,brainandbreast.Oncogene17,3499–350513Kittiniyom,K.,Gorse,K.M.,Dalbegue,F.,Lichy,J.H.,Taubenberger,J.K.andNewsham,I.F.(2001)Alleliclossonchromosomeband18p11.3occursearlyandrevealsheterogeneityinbreastcancerprogression.BreastCancerRes.3,192–198Received9January2002/15April2002;accepted25April2002PublishedasBJImmediatePublication25April2002,DOI10.1042/BJ2002006014Gutmann,D.H.,Donahoe,J.,Perry,A.,Lemke,N.,Kittinyom,K.,Rempel,S.A.,Gutierrez,J.A.andNewsham,I.F.(2000)LossofDAL-1,aProtein4.1-relatedtumorsuppressor,isanimportantearlyeventinthepathogenesisofmeningiomas.Hum.Mol.Genet.9,1495–150015Perry,A.,Dan,X.C.,Scheithauer,B.W.,Swanson,P.E.,Lohse,C.M.,Newsham,I.F.,Weaver,A.andGutmann,D.H.(2000)Merlin,DAL-1,andprogesteronereceptorexpressioninclinicopathologicsubsetsofmeningioma:acorrelativeimmunohistochemicalstudyof175cases.J.Neuropathol.Exp.Neurol.59,872–87916vanHemert,M.J.,Steensma,H.Y.andvanHeusden,G.P.H.(2001)14-3-3proteins:keyregulatorsofcelldivision,signallingandapoptosis.BioEssays23,936–94617Altschul,S.F.,Gish,W.,Miller,W.,Myers,E.W.andLipman,D.J.(1990)Basiclocalalignmentsearchtool.J.Mol.Biol.215,403–41018Xu,H.-M.andGutmann,D.H.(1998)Merlindiﬀerentiallyassociateswiththemicrotubuleandactincytoskeleton.J.Neurosci.Res.51,403–41519Muslin,A.J.,Tanner,J.W.,Allen,P.M.andShaw,A.S.(1996)Interactionof14-3-3withsignalingproteinsismediatedbytherecognitionofphosphoserine.Cell(Cambridge,Mass.)84,889–89720Fu,H.,Subramanian,R.R.andMasters,S.C.(2000)14-3-3proteins:structure,function,andregulation.Annu.Rev.Pharmacol.Toxicol.40,617–64721Baldin,V.(2000)14-3-3proteinsandgrowthcontrol.Prog.CellCycleRes.4,49–6022Skoulakism,E.M.C.andDavis,R.L.(1998)14-3-3proteinsinneuronaldevelopmentandfunction.Neurobiology16,269–28423Zhang,S.-H.,Kobayashi,R.,Graves,P.R.,Piwnica-Worms,H.andTonks,N.K.(1997)Serinephosphorylation-dependentassociationoftheband4.1-relatedprotein–tyrosinephosphatasePTPH1with14-3-3bprotein.Proc.Natl.Acad.Sci.U.S.A.272,27281–2728724Lehoux,S.,Abe,J.-I.,Forian,J.A.andBerk,B.C.(2001)14-3-3bindingtoNa+/H+exchangerisoform-1isassociatedwithserum-dependentactivationofNa+/H+exchange.J.Biol.Chem.276,15794–1580025Luk,S.C.,Ngai,S.M.,Tsui,S.K.,Fung,K.P.,Lee,C.Y.andWaye,M.M.(1999)Invivoandinvitroassociationof14-3-3eisoformwithcalmodulin:implicationforsignaltransductionandcellproliferation.J.Cell.Biochem.73,31–3526Gutmann,D.H.,Haipek,C.A.,Burke,S.P.,Sun,C.X.,Scoles,D.R.andPulst,S.M.(2001)TheNF2interactor,hepatocytegrowthfactor-regulatedtyrosinekinasesubstrate(HRS),associateswithmerlininthe‘open’conformationandsuppressescellgrowthandmotility.Hum.Mol.Genet.10,825–83427Murthy,A.,Gonzalez-Agosti,C.,Corder,D.,Pinney,D.,Candia,C.,Soloman,F.,Gusella,J.andRamesh,V.(1998)NHE-RF,aregulatorycofactorforNa+–H+exchange,isacommoninteractorformerlinandERM(MERM)proteins.J.Biol.Chem.273,1273–127628Jannatipour,M.,Dion,P.,Khan,S.,Jindal,H.,Fan,X.,Laganiere,J.,Chishti,A.H.andRouleau,G.A.(2001)Schwannominisoform-1interactswithsynteninviaPDZdomains.J.Biol.Chem.276,33093–3310029Goutebroze,L.,Brault,D.,Murchardt,C.,Camonis,J.andThomas,G.(2000)CloningandcharacterizationofSCHIP-1,anovelproteininteractingspeciﬁcallywithsplicedisoformsandnaturallyoccurringmutantNF2proteins.Mol.CellBiol.20,1699–171230Fantl,W.J.,Muslin,A.J.,Kikuchi,A.,Martin,J.A.,MacNichol,A.M.,Gross,R.W.andWilliams,L.T.(1994)ActivationofRaf-1by14-3-3proteins.Nature(London)371,612–61431Fu,H.,Xia,K.,Pallas,D.C.,Cui,C.,Conroy,K.,Narsimhan,R.P.,Mamon,H.,Collier,R.J.andRoberts,T.M.(1994)InteractionoftheproteinkinaseRaf-1with14-3-3proteins.Science266,126–12932Muslin,A.J.andXing,H.(2000)14-3-3proteins:regulationofsubcellularlocalizationbymolecularinterference.CellSignal.12,703–70933Robertson,H.,Langdon,W.Y.,Thien,C.B.F.andBowtell,D.D.L.(1997)Ac-Cblyeasttwo-hybridscreenrevealsinteractionswith14-3-3isoformsandcytoskeletalcomponents.Biochem.Biophys.Res.Commun.240,46–5034Bonnefoy-Berard,H.,Lio,Y.-C.,vonWillegrand,M.,Sung,A.,Elly,C.,Mustelin,R.,Yoshida,H.,Ishizaka,K.andAltman,A.(1995)Inhibitionofphosphatidylinositol3-kinaseactivitybyassociationwith14-3-3proteinsinTcells.Proc.Natl.Acad.Sci.U.S.A.92,10142–1014635Masters,S.C.andFu,H.(2001)14-3-3proteinsmediateanessentialanti-apoptoticsignal.J.Biol.Chem.276,45193–4520036Zha,J.,Harada,H.,Yang,E.,Jockel,J.andKorsmeyer,S.J.(1996)SerinephosphorylationofdeathagonistBADinresponsetosurvivalfactorresultsinbindingto14-3-3notBCL-X(L).Cell(Cambridge,Mass.)87,619–62837Masters,S.C.,Yang,H.,Datta,S.R.,Greenberg,M.E.andFu,H.(2001)14-3-3inhibitsBAD-inducedcelldeaththroughinteractionwithserine-136.Mol.Pharmacol.60,1325–1331#2002BiochemicalSociety